Protalix Biotherapeutics Inc. buy klostergang
Start price
08.04.15
/
50%
€18.27
Target price
08.10.15
€24.00
Performance (%)
-46.14%
End price
08.10.15
€9.84
Summary
This prediction ended on 08.10.15 with a price of €9.84. The BUY prediction by klostergang for Protalix Biotherapeutics Inc. performed very badly with a performance of -46.14%. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Protalix Biotherapeutics Inc. | 12.912% | 12.912% | -45.965% | -27.258% |
iShares Core DAX® | -3.429% | 5.085% | 15.455% | 12.600% |
iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% | 27.048% |
iShares Nikkei 225® | -7.364% | 5.479% | 6.970% | -3.061% |
iShares S&P 500 | -4.366% | 2.019% | 18.650% | 32.317% |
Comments by klostergang for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Protalix BioTherapeutics
Protalex recently received FDA clearance to begin a Phase 1/2 study with PRTX-100 in Immune Thrombocytopenia (ITP).
Previous data with PRTX-100 in patients with Rheumatoid Arthritis (RA) demonstrated the drug to be both safe and highly efficacious.
(Laufzeit überschritten)